Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
Key facts
- Where
- Abilene, Anaheim, Boys Town, Brooklyn, Charlotte, Doral, Durham, El Paso, Foley, Greenville, Harlingen, Indianapolis, Kingwood, Kissimmee, Mankato, Miami, Orlando, Peoria, Plano, Portland, San Antonio, Scottdale, Smithfield, South Miami, Sugar Land, The Bronx, and Wilmington, United StatesSee the 27 sites
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 18 years old?
Source: NCT05905926, who can take part
Where in United States
- Advance Clinical Trial PLLCAbilene, United StatesNo longer taking part
- Advanced Research Center, Inc.Anaheim, United StatesNo longer taking part
- Boys Town National Research HospitalBoys Town, United StatesNo longer taking part
- SUNY Downstate Medical CenterBrooklyn, United StatesNo longer taking part
- Atrium HealthCharlotte, United StatesNo longer taking part
- Prohealth Research CenterDoral, United StatesNo longer taking part
- Duke University School of MedicineDurham, United StatesNo longer taking part
- Maspons Pediatric GastroEl Paso, United StatesNo longer taking part
- G & L Research LLCFoley, United StatesNo longer taking part
- Prisma Health Children's HospitalGreenville, United StatesNo longer taking part
- Texas Digestive SpecialistsHarlingen, United StatesNo longer taking part
- Riley Children's HealthIndianapolis, United StatesNo longer taking part
- Frontier Clinical ResearchKingwood, United StatesNo longer taking part
- I.H.S Health, LLCKissimmee, United StatesNo longer taking part
- Mankato Clinic/ Javara Research LtdMankato, United StatesNo longer taking part
- Valencia Medical and Research CenterMiami, United StatesNo longer taking part
- Orlando Health, Inc.- APH Center for Digestive Health and NutritionOrlando, United StatesNo longer taking part
- OSF Saint Francis Medical CenterPeoria, United StatesNo longer taking part
- Aim Trials, LLCPlano, United StatesNo longer taking part
- Maine HealthPortland, United StatesNo longer taking part
- Sun Research InstituteSan Antonio, United StatesNo longer taking part
- Frontier Clinical Research, LLCScottdale, United StatesNo longer taking part
- Frontier Clinical Research, LLCSmithfield, United StatesNo longer taking part
- Florida Pharmaceutical Research and Associates, Inc.South Miami, United StatesNo longer taking part
- Pioneer Research Solutions IncSugar Land, United StatesNo longer taking part
- Advantage Clinical TrialsThe Bronx, United StatesNo longer taking part
- Wilmington HealthWilmington, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ardelyx
- Trial code
- NCT05905926
- Record updated
- 4 June 2026
- Original description
Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.Read full original descriptionShow less
An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 6 to Less Than 18 Years Old
Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.
Inclusion: ≥6 and <18 years old at enrollment of either parent study; Patient completed the parent study immediately with adequate compliance with study procedures in the opinion of the Investigator; Females of child-bearing potential must have negative pregnancy test at the last visit of the parent study and confirm the use of appropriate contraception (including abstinence); Subject is ambulatory; Written informed consent by parent/guardian/ Legally Authorized Representative (LAR) and a willingness of both subject and parent/guardian/LAR to participate in the study as it is described.
Exclusion: Any surgery on the stomach, small intestine or colon, excluding appendectomy or cholecystectomy; Patient discontinued prematurely from the parent study; Pregnant or lactating women; If, in the opinion of the Investigator, patient is unable or unwilling to fulfill the requirements of the protocol.